Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ovochymase-2 (OVCH2) is an **epididymis-specific serine protease** required for male fertility, particularly for the maturation of sperm in mammals[1][3][5][6]. OVCH2 orchestrates crucial **proteolytic processing of sperm surface proteins**, notably ADAM3, essential for sperm fertilizing competence[5][6]. It contains distinctive CUB domains, but its **protease (serine endopeptidase) activity rather than CUB domains is critical for functional sperm maturation**[1][3]. OVCH2 is primarily active in the **proximal caput of the epididymis** and is key for enabling sperm motility and function; disruption of this protease leads to impaired sperm processing and infertility, as observed in knockout models[1][5][6][7]. Due to its indispensable role in sperm maturation but lack of broader systemic expression, OVCH2 is considered a promising **non-hormonal male contraceptive target** and a candidate for genetic screening in cases of idiopathic male infertility[1][5][3]. No drugs that directly target OVCH2 are currently known, but its restricted expression and essential reproductive function highlight its potential as both a target and a biomarker in andrology research[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ovochymase-2 (OVCH2).